
We have developed a comprehensive portfolio of VEGF family proteins covering various species, iso...

As of April 1, 2026, the European Pharmacopoeia EP 2.6.7 (12.2) has officially come into effect, ...

Gruber et al. (2026) in their study “Targeted Delivery of a Potent STING Agonist Payload via an A...

ADC quality directly dictates clinical efficacy, patient safety, and batch-to-batch consistency—d...

In the complex landscape of monoclonal antibody (mAb) development, striking a balance between the...
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



